As the Covid-19 pandemic continues to overwhelm much of the world, the race for a vaccine is still the foremost priority among researchers.
Thankfully, that race could end soon, as a vaccine jointly developed by researchers in Singapore and America may be ready for use as early as next year.
This is following positive results from an earlier clinical trial that started a few months ago.
According to The Straits Times (ST), scientists from Duke-NUS and American pharmaceutical firm Arcturus Therapeutics released the news on Monday (9 Nov).
Clinical trials which began earlier this year have shown positive results, with patients showing no dangerous side effects.
Their immune systems also responded positively to the vaccine, which researchers found could be effective in only a single dose.
In light of these good signs, more money will be going into mass production of the vaccine.
To kickstart production, the Singapore Economic Development Board (EDB) will be channelling S$60.5 million into manufacturing the vaccine, reports ST.
They’ll also be buying large shipments which will come in from the first quarter of next year, which is by Mar 2021.
When exactly they’ll be widely available is unclear, so let’s keep a lookout for updates from the Ministry of Health (MOH).
While existing measures like mask-wearing and safe distancing have been effective in curbing infections, a vaccine will be a godsend.
Hopefully when we can all have access to it, there’ll be a greater guarantee of protection against the virus.
Maybe then, too, we can finally return to life as we knew it before the pandemic without worrying about viral transmissions anymore.
This news is making us optimistic for a better year ahead, so let’s keep our fingers crossed.
Have news you must share? Get in touch with us via email at hello@mustsharenews.com.
Featured image adapted from Sengkang General Hospital.
He had been an indelible part of the neighbourhood.
The S$6 bowl "lacked flavour" as it had fewer ingredients, customers had reportedly said.
The movie is showing at all the other cinema chains in Singapore.
The move is in the public interest "given NTUC's close nexus and symbiotic relationship with"…
Investigations by SFA and MOH are ongoing.
Each shirt is priced at S$15.90, with the proceeds supporting lower-income residents in Sembawang Central.